Form 4 for LH Labcorp
Accepted 2021-11-03 00:00:00 ET · period of report 2021-11-01 · accession 0001127602-21-028238 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-03 | 2021-11-01 | LH | EISENBERG GLENN A | CFO, EVP | F - Tax | $288.78 | -4,034 | 42.4K | -9% | -$1.16M |
| D | 2021-11-03 | 2021-11-01 | LH | EISENBERG GLENN A | CFO, EVP | M - OptEx | — | +9,024 | 46.5K | +24% | — |
| D | 2021-11-03 | 2021-11-01 | LH | EISENBERG GLENN A | CFO, EVP | M - OptEx | $0.00 | -9,024 | 17.2K | -34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-01 | F | D | 4,034 | $288.78 | 42,423 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-01 | M | A | 9,024 | — | 46,457 | D | — | — | (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. |
| 3 | Derivative | Restricted Stock Unit | 2021-11-01 | M | D | 9,024 | $0.00 | 17,212 | D | — · — to — | 9,024 Common Stock | (F4) This number reflects the aggregate number of Restricted Stock Units held by the reporting person. (F1) Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. (F3) The Restricted Stock Units that have vested were part of a grant that vests in three installments as follows: 30% of the Restricted Stock Units vested on November 1, 2020; 30% of the Restricted Stock Units vested on November 1, 2021; and 40% of the Restricted Stock Units will vest on November 1, 2022, with the third installment subject to a relative total shareholder return ("TSR") modifier that may adjust the third installment of the Restricted Stock Units upward or downward 25% based on our three-year cumulative relative TSR. |